Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PTC | U |
|---|---|---|
| Price | $145.53 | $43.07 |
| Change today | ▲ 3.73% | ▲ 5.22% |
| Market cap | $15.79B | $18.95B |
| Return, 3 months | +21.5% | +42.6% |
| Return, year to date | -16.5% | -2.5% |
| Return, 1 year | -28.1% | +12.4% |
| P/E (TTM) | 14.1 | -31.7 |
| P/B | 4.6 | 6.2 |
| P/E percentile vs own 5y | 5th | 25th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -6.8% | +23.9% |
| Net profit growth (YoY) | -16.0% | +78.9% |
| Gross margin | 84.5% | 64.9% |
| Operating margin | 38.2% | -30.4% |
| Net margin | 41.4% | -29.0% |
| Return on equity | 35.1% | -18.9% |
| Analyst target vs. price | +16.3% | +13.1% |
| Analyst buy share | 67% | 88% |
| RSI (14) | 51 | 47 |
| 30-day volatility | 41.7% | 37.8% |
| Max drawdown, 1 year | -45.5% | -65.4% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
